comparemela.com
Latest Breaking News On - Obtained additional application - Page 1 : comparemela.com
Nippon Shinyaku : UCB Japan Obtained Additional Application of Fintepla® (fenfluramine) for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome in Japan -March 26, 2024 at 03:06 am EDT
NEWS RELEASE March 26, 2024 UCB Japan Obtained Additional Application of Fintepla® for the Treatment of Seizures.
Tokyo
Japan
Brussels
Bruxelles-capitale
Belgium
Kyoto
Japanese
Toru-nakai
Kanako-kikuchi
Zogenix-inc
Japan-co
Corporate-communications-dept
vimarsana © 2020. All Rights Reserved.